Nu-Med Plus Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Selling, General & Admin	0.05	0.06	0.12	0.18	0.83	Upgrade
Operating Expenses	0.05	0.06	0.12	0.18	0.84	Upgrade
Operating Income	-0.05	-0.06	-0.12	-0.18	-0.84	Upgrade
Interest Expense	-0.01	-0.01	-0.01	-0	-	Upgrade
EBT Excluding Unusual Items	-0.06	-0.07	-0.13	-0.18	-0.84	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	0	-	Upgrade
Other Unusual Items	-	-	-	0.05	0.01	Upgrade
Pretax Income	-0.06	-0.07	-0.13	-0.13	-0.83	Upgrade
Net Income	-0.06	-0.07	-0.13	-0.13	-0.83	Upgrade
Net Income to Common	-0.06	-0.07	-0.13	-0.13	-0.83	Upgrade
Shares Outstanding (Basic)	84	84	82	80	73	Upgrade
Shares Outstanding (Diluted)	84	84	82	80	73	Upgrade
Shares Change (YoY)	-	2.30%	2.15%	8.96%	34.60%	Upgrade
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.01	Upgrade
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	-0.01	Upgrade
Free Cash Flow	-0.05	-0	-0.07	-0.04	-0.21	Upgrade
Free Cash Flow Per Share	-0.00	-	-0.00	-	-0.00	Upgrade
EBITDA	-	-	-0.12	-0.18	-0.83	Upgrade
D&A For EBITDA	-	-	0	0	0.01	Upgrade
EBIT	-0.05	-0.06	-0.12	-0.18	-0.84	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.